Abiopharma

Cognition Therapeutics Announces $30 Million Registered Direct Offering of Common Stock

NASDAQ traded attribute type Security_Name was changed. Previous value: ModivCare Inc. - Common Stock. New value: ModivCare Inc. - Common Stock.

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: ModivCare Inc. - Common Stock.

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: ModivCare Inc. - Common Stock.

Reshaping operational efficiency with VR and AR technology

IMVT Investors Have Opportunity to Join Immunovant, Inc. Fraud Investigation with the Schall Law Firm

New Form 144 - Fulgent Genetics, Inc. Filed: 2025-08-27 AccNo: 0001819718-25-000012 Size: 7 KB

New Form 144 - Fulgent Genetics, Inc. Filed: 2025-08-27 AccNo: 0001684532-25-000008 Size: 7 KB

General Announcement: Request for Lifting of Trading Halt - Sponsors Statement

Request for Lifting of Trading Halt: Request for Lifting of Trading Halt

CLINUVEL delivers ninth consecutive year of revenues growth and profit

Investor Presentation

Appendix 4G

Appendix 4G and Corporate Governance Statement

Dividend/Distribution – CUV